Variables | Groups | |
---|---|---|
Training group | Low risk (n = 51) | High risk (n = 51) |
Deaths—no. (%)a | 2 | 15 |
Data censoredb | 49 | 36 |
Median overall survival—mo (95% CI) | NE | NE |
The overall survival (95% CI) by Kaplan–Meier estimation | ||
 3.60 mo | NA | 98 (94.3–1) |
 10.70 mo | NA | 90.2 (82.4–98.7) |
 13 mo | 98 (94.2–1) | 84.3 (74.9–94.9) |
 23.57 mo | NA | 82.3 (72.5–93.5) |
 27 mo | 96 (90.7–1) | 76.2 (65.3–88.9) |
 31 mo | NA | 73.9 (62.6–87.2) |
 31.5 mo | NA | 68.6 (56.4–83.5) |
Validation group (TCGA data) | Low risk (n = 261) | High risk (n = 261) |
---|---|---|
Deaths—no. (%)a | 62 | 125 |
Data censoredb | 199 | 136 |
Median overall survival—mo (95% CI) | 77.3 (55.1–NE) | 36 (31.6–42.2) |
The overall survival (95% CI) by Kaplan–Meier estimation | ||
36–39.8 mo | 75.4 (68.77–82.7) | 49.9 (42.95–58.1) |
77–79 mo | 48.7 (38.29–61.8) | 25.1 (17.72–35.6) |
106–112 mo | 42.6 (29.85–60.7) | 15.2 (8.21–28.2) |